1-184795414-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052966.4(NIBAN1):āc.2350G>Cā(p.Glu784Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,606,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_052966.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIBAN1 | NM_052966.4 | c.2350G>C | p.Glu784Gln | missense_variant | 14/14 | ENST00000367511.4 | NP_443198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIBAN1 | ENST00000367511.4 | c.2350G>C | p.Glu784Gln | missense_variant | 14/14 | 1 | NM_052966.4 | ENSP00000356481 | P1 | |
NIBAN1 | ENST00000417056.5 | c.260+2665G>C | intron_variant | 3 | ENSP00000414039 | |||||
NIBAN1 | ENST00000487074.5 | n.1822G>C | non_coding_transcript_exon_variant | 9/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33
GnomAD4 exome AF: 6.87e-7 AC: 1AN: 1454754Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 723168
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152214Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.2350G>C (p.E784Q) alteration is located in exon 14 (coding exon 14) of the FAM129A gene. This alteration results from a G to C substitution at nucleotide position 2350, causing the glutamic acid (E) at amino acid position 784 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at